This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
ETF Strategies to Gain From the Stimulus & Vaccine Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from optimism surrounding another trench of coronavirus-aid package and coronavirus vaccine development.
Take a Look at These 5 ETFs to Ride the Market Bulls
by Sweta Jaiswal, FRM
It is being believed that the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout are making a strong case in favor of faster U.S. economic recovery in 2021.
Buy High-Beta & Momentum ETFs to Follow J.P. Morgan's Vision
by Sanghamitra Saha
The chief investment officer at JPMorgan Asset Management Bob Michele does not see overvaluation in Wall Street and suggested investors to join the rally.
Play These ETF Strategies to Ride the US Market Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from optimism surrounding the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout.
3 Reasons Setting the Tone Right for Momentum ETFs
by Sweta Jaiswal, FRM
Here we highlight some momentum ETFs that are lucrative investment picks given the current market optimism.
5 High Beta & Momentum ETFs to Tap the Santa Rally
by Sweta Killa
These ETFs are expected to outperform in the seven-day period and are intriguing choices for a short spell.
Get Your Portfolio Christmas-Ready With These ETFs
by Sweta Jaiswal, FRM
Here we highlight some ETFs that can help investors make the most of the favorable investing opportunities amid the coronavirus crisis.
Grab These ETFs Now for an Impressive Finish to 2020
by Sweta Jaiswal, FRM
Here we highlight some ETFs that can help investors make the most of the favorable investing opportunities amid the coronavirus crisis.
ETF Strategies to Gain From Vaccine Hopes & Biden's Transition
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the upbeat coronavirus vaccine data amid the health crisis.
Momentum ETFs to Play on Coronavirus Vaccine Hopes
by Sweta Jaiswal, FRM
Here we highlight some momentum ETFs that are lucrative investment picks now on the flowing in of positive news regarding coronavirus vaccine.